deltatrials
Recruiting OBSERVATIONAL NCT03296202

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV (AquiVIH-NA)

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA

Sponsor: French Ministry of Health through the COREVIH Aquitaine

Conditions Antiretroviral Agents HIV Infections
Updated 15 times since 2017 Last updated: Feb 19, 2025 Started: Jul 18, 2017 Primary completion: Jul 31, 2025 Completion: Jul 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Antiretroviral Agents and HIV Infections and is currently actively recruiting participants. French Ministry of Health through the COREVIH Aquitaine leads this study, which shows 15 recorded versions since 2017 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshot~Aug 2019 – ~Jan 2020 · 5 months · monthly snapshot~Jan 2020 – ~Nov 2020 · 10 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Oct 2021 · 6 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Mar 2025 — Sep 2025 [monthly]

    Recruiting

  3. Sep 2024 — Mar 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Dec 2021 — Jul 2024 [monthly]

    Recruiting

▶ Show 10 earlier versions

  1. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  2. Apr 2021 — Oct 2021 [monthly]

    Recruiting

  3. Jan 2021 — Apr 2021 [monthly]

    Recruiting

  4. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  5. Jan 2020 — Nov 2020 [monthly]

    Recruiting

  6. Aug 2019 — Jan 2020 [monthly]

    Recruiting

  7. Jun 2018 — Aug 2019 [monthly]

    Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  10. Oct 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • French Ministry of Health through the COREVIH Aquitaine
  • Institut National de la Santé Et de la Recherche Médicale, France
  • National Agency for Research on AIDS and Viral Hepatitis (ANRS)
  • University Hospital, Bordeaux
Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Agen, France , Angoulême, France , Bayonne, France , Bordeaux, France , Châtellerault, France , Dax, France , Jonzac, France , La Teste-de-Buch, France , Libourne, France , Mont-de-Marsan, France and 9 more locations